Nucleate GVA | PATH: Intellectual Property Strategy for Life Science Founders
Speaker: Dr. Chris Vindurampulle (Principal, Patent and Trade Marks Attorney at Griffith Hack)
Are you a life science researcher thinking about turning your discovery into a biotech startup? Learn how to think strategically about intellectual property, protect inventions before disclosure, and avoid common IP pitfalls on the path from lab discovery to commercialization.
Turning academic research into a biotech company requires more than strong science. It also means understanding what kinds of intellectual assets you are creating, when to protect them, who owns them, and whether your future company will have the freedom to operate. In this session, Dr. Chris Vindurampulle, featured by the Nucleate Global Virtual Activator team, will walk through the key IP considerations researchers should understand when translating research into a startup.
Questions: [email protected]
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!: